循环RNAcircHIPK2通过miR-373-3p/RGMA轴抑制结肠癌细胞
Jie Lun1, Yuying Zhang2, Mengchao Yu3
1Department of Oncology, The Affiliated Hospital of Qingdao University, Qingdao Cancer Institute, Qingdao University, Qingdao, 266071, China; School of Pharmacy, Qingdao University, Qingdao, 266071, China.
Cancer letters
|May 18, 2024
概括
像cirHIPK2这样的循环RNAs (circRNAs) 在结肠癌中被下调,促进瘤生长. circHIPK2通过miR-373-3p/RGMA/BMP途径抑制癌症,提供潜在的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 循环RNAs (circRNAs) 在癌症中起作用,但它们的特定功能和调节尚未完全理解.
- 结肠癌的进展涉及复杂的分子变化,需要识别新的生物标志物和治疗点.
研究的目的:
- 研究circHIPK2在结肠癌发展中的作用和机制.
- 探索HOXD10,circHIPK2和结肠癌进展之间的调节关系.
主要方法:
- 定量实时PCR (qRT-PCR) 用于测量circHIPK2和HOXD10的表达.
- 在体外测试 (增殖,迁移,入侵) 和体内瘤异种移植模型.
- 机制研究涉及RNA免疫沉降 (RIP) 和光酶记者试验,以阐明circHIPK2/miR-373-3p/RGMA轴.
主要成果:
- 在结肠癌组织中,circHIPK2被显著下调,与晚期瘤等级和低生存率相关.
- 发现转录因子HOXD10调节circHIPK2的表达,并且在结肠癌中也被下调.
- 低circHIPK2表达促进结肠癌细胞的增殖,迁移,入侵,瘤生长和转移通过海绵miR-373-3p调节RGMA并激活BMP/Smad信号.
结论:
- circHIPK2在结肠癌中起到瘤抑制作用,抑制细胞增殖,迁移,入侵和转移.
- 这种circHIPK2/miR-373-3p/RGMA/BMP信号通路代表了结肠癌中一种新的机制.
- circHIPK2具有作为结肠癌预后生物标志物和治疗点的潜力.
相关概念视频
02:15Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
01:22MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
01:23RNA Interference
26.0K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.0K
02:34Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
02:57piRNA - Piwi-interacting RNAs
6.8K
PIWI-interacting RNAs, or piRNAs, are the most abundant short non-coding RNAs. More than 20,000 genes have been found in humans that code for piRNAs while only 2000 genes have been found for miRNAs. piRNAs can act at the transcriptional and post-transcriptional levels and have a vital role in silencing transposable elements present in germ cells. They are also involved in epigenetic silencing and activation. Previously, they were thought to function only in germ cells but new evidence suggests...
6.8K
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K